{"id":22740,"date":"2022-11-09T13:25:32","date_gmt":"2022-11-09T12:25:32","guid":{"rendered":"https:\/\/porib.com\/?p=22740"},"modified":"2022-11-18T13:00:00","modified_gmt":"2022-11-18T12:00:00","slug":"cordoba-r-lopez-corral-l-presa-m-martin-escudero-v-casado-ma-pardo-c","status":"publish","type":"post","link":"https:\/\/porib.com\/en\/cordoba-r-lopez-corral-l-presa-m-martin-escudero-v-casado-ma-pardo-c\/","title":{"rendered":"C\u00f3rdoba R, L\u00f3pez-Corral L, Presa M, Mart\u00edn-Escudero V, Casado M\u00c1, Pardo C"},"content":{"rendered":"<div class=\"col80\">\n<p class=\"miniatura_foto\" style=\"text-align: justify;\"><strong><img loading=\"lazy\" decoding=\"async\" class=\"size-full wp-image-14157 alignleft\" src=\"https:\/\/porib.com\/wp-content\/uploads\/2021\/09\/ISPOR.jpg\" alt=\"\" width=\"120\" height=\"120\" \/><\/strong><\/p>\n<p style=\"text-align: justify;\"><strong style=\"text-align: justify;\">C\u00f3rdoba R, L\u00f3pez-Corral L, Presa M, Mart\u00edn-Escudero V, Casado M\u00c1, Pardo C<\/strong><\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<\/div>\n<div class=\"col80\">\n<div class=\"col80p\">\n<h6><\/h6>\n<h6 style=\"text-align: justify;\">Value of Axicabtagene Ciloleucel Versus Chemotherapy in the Large B-Cell Lymphoma Treatment: Health Outcomes Based on the Number of Patients Treated in Spain<\/h6>\n<h6 style=\"text-align: justify;\"><strong>25th Annual European Congress International Society for Pharmacoeconomics &amp; Outcomes Research (ISPOR). Viena (Austria). 06-09 nov 2022<\/strong><\/h6>\n<p><a href=\"https:\/\/porib.com\/wp-content\/uploads\/2022\/11\/335.pdf\" target=\"_blank\" rel=\"noopener\">POSTER<\/a><\/p>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>C\u00f3rdoba R, L\u00f3pez-Corral L, Presa M, Mart\u00edn-Escudero V, Casado M\u00c1, Pardo C &nbsp; &nbsp; Value of Axicabtagene Ciloleucel Versus Chemotherapy in the Large B-Cell Lymphoma Treatment: Health Outcomes Based on the Number of Patients Treated in Spain 25th Annual European Congress International Society for Pharmacoeconomics &amp; Outcomes Research (ISPOR). Viena (Austria). 06-09 nov 2022 POSTER<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"quote","meta":{"footnotes":""},"categories":[116,933,246],"tags":[],"class_list":["post-22740","post","type-post","status-publish","format-quote","hentry","category-ace-acu-tipo-de-proyecto","category-hematologia-oncohematologia","category-international-society-of-pharmacoeconomics-and-outcomes-research","post_format-post-format-quote"],"translation":{"provider":"WPGlobus","version":"2.10.3","language":"en","enabled_languages":["es","en"],"languages":{"es":{"title":true,"content":true,"excerpt":false},"en":{"title":false,"content":false,"excerpt":false}}},"_links":{"self":[{"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/posts\/22740"}],"collection":[{"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/comments?post=22740"}],"version-history":[{"count":4,"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/posts\/22740\/revisions"}],"predecessor-version":[{"id":22897,"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/posts\/22740\/revisions\/22897"}],"wp:attachment":[{"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/media?parent=22740"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/categories?post=22740"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/tags?post=22740"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}